ácidos grasos omega-9

Omega-9 Fatty Acids: A Comprehensive Reference

1. Identity: Chemical Names, Classification, and Natural Sources

1.1 Definition and Chemical Classification

Omega-9 fatty acids (also known as n-9 fatty acids or ω-9 fatty acids) are a family of unsaturated fatty acids that have in common a final carbon-carbon double bond in the n-9 position — that is, the ninth bond, counting from the methyl end of the fatty acid. Omega-9 fatty acids are monounsaturated, meaning they only have one double bond, located nine carbons from the omega end of the fatty acid molecule.

Omega-9 fatty acids are synthesized endogenously in humans, though not fully compensating all body requirements; consequently, they are considered as partially essential fatty acids. This distinguishes them from omega-3 and omega-6 fatty acids, which are classified as fully essential because the human body cannot synthesize them at all. In contrast to omega-3 and omega-6 FA, omega-9 FA are not essential because humans are capable of synthesizing oleic acid (OA) from stearic acid in a reaction catalyzed by Δ9-desaturase.

1.2 Principal Members of the Omega-9 Family

The most common omega-9 fatty acids are hypogeic acid (16:1 (n-9), (Z)-hexadec-7-enoic acid), oleic acid (18:1 (n-9), (Z)-octadec-9-enoic acid), elaidic acid (18:1 (n-9), (E)-octadec-9-enoic acid), gondoic acid (20:1 (n-9), (Z)-eicos-11-enoic acid), mead acid (20:3 (n-9), (5Z,8Z,11Z)-eicosa-5,8,11-trienoic acid), erucic acid (22:1 (n−9), (Z)-docos-13-enoic acid), and nervonic acid (24:1 (n−9), (Z)-tetracos-15-enoic acid).

• Oleic acid (OA; 18:1 n-9): Oleic acid is the most common omega-9 fatty acid and the most common monounsaturated fatty acid in the diet. Chemically, oleic acid has the molecular formula CH₃−(CH₂)₇−CH=CH−(CH₂)₇−COOH. Its structure is characterized by one double bond in the cis configuration.
• Erucic acid (22:1 n-9): A very long-chain monounsaturated omega-9 fatty acid found in rapeseed (canola) and mustard seed oils.
• Mead acid (20:3 n-9): An omega-9 fatty acid that is synthesized endogenously during essential fatty acid deficiency, serving as a biochemical marker for this condition.
• Nervonic acid (24:1 n-9): As the major monounsaturated fatty acid in sphingomyelin that contributes to the formation of the myelin sheath, nervonic acid is crucial for the development and maintenance of the brain and nervous system.
• Gondoic acid (20:1 n-9): A lesser-studied very long-chain member of the family, also found in various plant oils.
• Elaidic acid (18:1 n-9, trans configuration): The trans isomer of oleic acid, primarily arising from partial hydrogenation of vegetable oils. Higher circulating elaidic acid is connected with increased long-term morbidity and mortality in the general population, and plasma elaidic acid levels are linked to an elevated risk of cardiovascular disease mortality.

Oleic acid has received the most research attention (23,588 citations in PubMed) compared to hypogeic acid (5 results in PubMed), elaidic acid (516), gondoic acid (34), mead acid (145), erucic acid (699), and nervonic acid (204), as searched in April 2021.

1.3 Natural Sources

Olive oil is considered one of the richest food sources of omega-9, with 83 grams of omega-9s per 100 grams. Other oils such as cashew, almond, avocado, and peanut are also relatively good sources, while foods like almonds, cashews, peanut butter, and walnuts also offer some omega-9s.

Oleic acid is the most abundant in many vegetable oils: it represents 40.7% of sesame oil, 17.5% of flaxseed oil, 74.8% of olive oil, 58.8% of rapeseed oil, and 32.7% of pumpkin seed oil.

Modern canola oil is bred to be low in erucic acid due to historical concerns about cardiac toxicity at very high doses. Erucic acid (22:1, n−9) is found in rapeseed, wallflower seed, and mustard seed.

Sources of nervonic acid include king salmon, the seed of yellow mustard, flaxseed, sockeye salmon, sesame seed, and macadamia nuts.

Oleic acid (18:1ω9), a monounsaturated fatty acid, is the major fatty acid in human milk. The main omega-9 fatty acid in the brain is oleic acid (18:1ω9), but there are also large quantities of long-chain derivatives, mainly 24:1, especially in the myelin sheath.

1.4 Common Forms and Preparations as a Supplement

Omega-9 fatty acids are consumed primarily in the form of dietary oils rather than isolated supplements. Extra virgin olive oil (EVOO) — obtained by cold-pressing of Olea europaea fruit — is the canonical food source. High-oleic sunflower oil, high-oleic canola oil, avocado oil, and macadamia nut oil are other commercially available options. Omega-9s themselves do not have the same robust body of scientific research as omega-3 fatty acids. Because the generally accepted recommendation is to not add more overall fats, but rather replace saturated and/or trans-fats with monounsaturated or polyunsaturated fats, omega-9 supplements are less commonly recommended.

In the context of adrenoleukodystrophy (ALD), a specific pharmaceutical preparation is used. Lorenzo's oil is a liquid solution made of 4 parts glycerol trioleate and 1 part glycerol trierucate, which are the triacylglycerol forms of oleic acid and erucic acid, prepared from olive oil and rapeseed oil.

Combined omega-3-6-9 supplements sold in capsule form are available commercially. Combined omega-3-6-9 supplements provide combinations of fatty acids; however, they likely provide no additional benefits compared with omega-3 supplements alone.

2. Traditional and Historical Use

2.1 Olive Oil in Ancient Civilizations

The history of the primary dietary source of omega-9 — olive oil — is among the longest documented for any food. Olive oil has deep roots in Mediterranean history, dating back over 6,000 years. Ancient civilizations such as the Egyptians, Greeks, Romans, and Phoenicians cultivated olive trees, recognizing the oil's medicinal, culinary, and spiritual significance.

Olive oil has been used since antiquity, with evidence of its use dating back to the ancient Minoan civilization in Crete. It was highly valued by the ancient Greeks and Romans, who prized it for its health benefits and culinary properties. In ancient Rome, olive oil was used for everything from body care to medicine, and it is still used in many traditional medical treatments today.

In the Middle Ages, olive trees were spread from the Mediterranean across Europe, and by the 16th century, they had become a staple in European diets. During this period, olive oil was also widely used in religious ceremonies and as a fuel for lamps.

2.2 The Mediterranean Diet Tradition

The Mediterranean diet originates in the food cultures of ancient civilizations which developed around the Mediterranean Basin, and is based on the regular consumption of olive oil (as the main source of added fat), plant foods (cereals, fruits, vegetables, legumes, tree nuts, and seeds), the moderate consumption of fish, seafood, and dairy, and low-to-moderate alcohol (mostly red wine) intake, balanced by a comparatively limited use of red meat and other meat products.

A few decades ago, the Mediterranean diet drew the attention of medical professionals by proving extended health benefits. The first reports ascertained cardiovascular protection, as multiple large-scale clinical studies, starting with Ancel Keys' Seven Countries Study, showed a marked reduction of atherosclerotic clinical events in populations with a Mediterranean dietary pattern.

2.3 Erucic Acid in Traditional Asian and European Cuisine

Erucic acid significantly exists in the Asian diet. Mustard seed oil, which is a significant source of erucic acid, has been used for centuries across South Asian and East Asian culinary traditions for cooking, preservation, and traditional medicine. Rapeseed oil, another major source, has been cultivated in Northern Europe and China for culinary and industrial purposes for many centuries.

3. Key Constituents and Established Mechanisms of Action

3.1 Endogenous Synthesis

Oleic acid is not an essential fatty acid since it can be synthesized endogenously via stearoyl-CoA desaturase; however, it plays critical roles in cellular structure, metabolic homeostasis, inflammation regulation, and cardio-metabolic health. Competition from linoleic acid (18:2ω-6) and alpha-linolenic acid (18:3ω-3) for Δ6 desaturase prevents the formation and accumulation of more unsaturated ω-9 acids; but under conditions of severe omega-3 and omega-6 deprivation, humans elongate and desaturate oleic acid to make Mead acid (C20:3ω−9).

Mead acid is produced from oleic acid (18:1n-9) by two desaturation enzymes (Fads1 and Fads2) and one elongation enzyme (Elovl5). Mead acid was first identified by Mead and Slaton in rats fed a fat-deficient diet and was determined to be derived from oleic acid.

3.2 Membrane Structure and Fluidity

Oleic acid is one of the most abundant fatty acids in human adipose tissue, cell membranes, and plasma lipoproteins. Its single cis double bond (C18:1 n-9) provides membrane flexibility while maintaining oxidative stability superior to polyunsaturated fatty acids (PUFAs). By quantity, oleic acid is the most important omega-9 fatty acid in both plant oils as well as animal tissues and is a major constituent of biomembranes.

3.3 Anti-inflammatory Signaling

Oleate protects against cardiovascular insulin resistance, improves endothelial dysfunction, inflammation and reduces proliferation and apoptosis in vascular smooth muscle cells (VSMCs) that may contribute to an ameliorated atherosclerotic process. These processes may be mediated by inhibition of JNK-1/2 and NF-κB pathways.

Oleic acid supplementation in hereditary hypertriglyceridemic rats affected mainly n6-PUFA metabolism — especially arachidonic acid metabolism — and oleic acid-treated rats exhibited not only decreased arachidonic acid profiles but also decreased proinflammatory arachidonic acid-derived metabolites (HETEs) in peripheral tissues, which could ultimately reduce chronic inflammation.

The observed anti-inflammatory effects reported for oleic acid, mead acid, and erucic acid were directed to attenuate inflammation in several physiological and pathological conditions such as wound healing and eye inflammation, by altering the production of inflammatory mediators, modulating neutrophil infiltration, and altering the VEGF effector pathway.

3.4 Lipid Metabolism and Cholesterol Regulation

A diet higher in oleic acid or lower in linoleic acid decreases LDL susceptibility to oxidation. It is likely that both oleic acid and phenolic compounds in extra virgin olive oil (EVOO) contribute to observed changes in arterial blood pressure and blood lipids.

3.5 Insulin Sensitivity Mechanisms

Oleic acid was found to be effective in reversing the inhibitory effect on insulin production of the inflammatory cytokine TNF-α. This finding is consistent with the reported therapeutic characteristics of other monounsaturated and polyunsaturated fatty acids.

3.6 Nervonic Acid and Myelination

During fetal development and infancy, nervonic acid supports the rapid expansion of neural networks, the formation of myelin, and the structural integrity of cellular membranes — processes critical for cognitive and motor function maturation. Nervonic acid biosynthesis is particularly active in the liver and brain during early life, driven by the elongation of oleic (18:1 n-9), gondoic (20:1 n-9), and erucic (22:1 n-9) acids.

Studies indicate that nervonic acid supplementation can enhance myelin synthesis in oligodendrocytes, promoting nerve maturation. Once produced, nervonic acid is incorporated into sphingomyelin and gangliosides, which are major lipid constituents of the myelin sheath that insulates axons, enabling rapid and efficient nerve impulse conduction. Nervonic acid facilitates proper signal transduction and cell recognition, contributing to optimal neural connectivity and long-term neurodevelopmental outcomes.

3.7 Erucic Acid and Very Long-Chain Fatty Acid Metabolism

The administration of oleic and erucic acids inhibits the synthesis of very-long-chain fatty acids. Erucic acid can also be transformed into nervonic acid, a crucial element of myelin; therefore, erucic acid may have remyelinating effects, which may be crucial for treating different demyelinating conditions.

4. Scientific Evidence by Area of Use

4.1 Cardiovascular Health

FDA Qualified Health Claim

Consuming oils rich in oleic acid reduces the risk of heart disease. The FDA allows for this qualified health claim on certain products. Its benefits might be related to its effects on cholesterol levels and inflammation. Consuming oils that provide about 20 grams (1.5 tablespoons) of oleic acid in place of dietary fats with higher amounts of saturated fat might reduce the risk of heart disease.

PREDIMED Trial

The PREDIMED Study, a randomized trial conducted in Spain (2003–2009) with people at high risk of cardiovascular disease, demonstrated that a long-term intervention with a Mediterranean diet reinforced with virgin olive oil (50 mL/day) reduced the incidence of major cardiovascular events (Estruch R et al., N Engl J Med. 2013, 368, 1279–1290), and caused a significant 40% reduction of the relative risk for diabetes.

LDL Cholesterol and Lipid Profile

A randomized, controlled, blind, crossover intervention was carried out in healthy and at-risk (hypercholesterolemic) subjects, where participants consumed daily 45 g of olive pomace oil (OPO) or high-oleic acid sunflower oil (HOSO) as control oil during 4 weeks. OPO significantly reduced LDL cholesterol (P = 0.003) and apolipoprotein B (Apo B; P = 0.022) serum concentrations, and LDL/HDL ratio (P = 0.027) in healthy and at-risk volunteers.

The Mediterranean diet supplemented with olive oil or nuts has been shown to reduce the incidence of major cardiovascular events in individuals with elevated cardiovascular disease risk. The Mediterranean diet has also been shown to be effective in secondary prevention of coronary heart disease. Many key components of this diet including olive oil and nuts are rich sources of monounsaturated fatty acids (MUFAs).

Evidence Strength

The cardiovascular evidence for omega-9 fatty acids — principally oleic acid from olive oil — is among the strongest for any dietary fatty acid. The PREDIMED trial was a large, multicenter, randomized controlled trial. However, it is important to note that olive oil contains numerous bioactive compounds beyond oleic acid (including polyphenols and vitamin E), making it difficult to attribute effects exclusively to the omega-9 component. The data support evidence from prospective clinical trials such as the PREDIMED trial, that diets rich in oleic acid from vegetable oils have benefits for cardiovascular health.

4.2 Glucose Metabolism and Insulin Sensitivity

The relationship between dietary oleic acid and insulin sensitivity has been studied in multiple designs. A meta-analysis of four cohort studies and 29 randomized controlled trials on the effects of olive oil-enriched diets on risk of type 2 diabetes (DM2) associated olive oil intake with a decreased risk to develop DM2 in healthy individuals and an improved glucose metabolism in patients with already established diabetes.

In a study investigating oleic acid and insulin, oleic acid was shown to increase insulin production and to reverse the inhibitory insulin effect of TNF-α. Peanut oil, high in oleic acid, was able to ameliorate the diabetic symptoms of type II diabetic mice characterized by inflammation. The findings are consistent with earlier clinical and epidemiological findings that peanuts are beneficial in lowering the risk of type 2 diabetes in women.

Oleic acid is also used for diabetes and high blood pressure, but there is no good scientific evidence to support most of these uses when considering oleic acid as an isolated supplement distinct from dietary patterns. Most supporting evidence is derived from dietary pattern studies (i.e., the Mediterranean diet) rather than from isolated oleic acid supplementation trials, which limits causal attribution.

4.3 Anti-Inflammatory Effects

The Mediterranean diet, rich in olive oil, is beneficial, reducing the risk of cardiovascular diseases and cancer. Olive oil is mostly composed of the monounsaturated fatty acid omega-9. Research showed omega-9 protects septic mice modulating lipid metabolism, and the significant reduction of inflammation detected after omega-9 enteral injection can further contribute to the already known beneficial properties facilitated by unsaturated fatty acid-enriched diets.

This is predominantly animal and in vitro evidence. These effects have yet to be confirmed using randomized controlled trials to reveal solid conclusive evidence for comparative actions using isolated oils enriched in certain omega-9 fatty acids or individual fatty acids. Execution of more epidemiological studies with more advanced methodologies (lipidomics, metabolomics, and molecular techniques) will yield more reliable information about omega-9 action mechanisms at different cellular levels.

4.4 Cancer — Breast Cancer and HER2 Oncogene

Exogenous supplementation of cultured cancer cells with physiological concentrations of the ω-9 MUFA oleic acid drastically suppressed the expression and activity of HER2 (erbB-2), one of the most commonly analyzed proto-oncogenes in human cancer studies, as it plays a pivotal role in oncogenic transformation, tumorigenesis, and metastasis. Patients with HER2-overexpressing cancer are associated with unfavorable prognosis, shorter relapse time, and low survival rate. These findings suggested that supplementation with olive oil may represent a promising dietary intervention for the prevention and/or management of HER2-related carcinomas.

The anti-neoplastic action of omega-9 fatty acids is controversial compared to its anti-inflammatory actions, with the effect varying with the type of cancerous tissue and the effector pathway. Most documented anti-neoplastic action of omega-9 is evidenced in the case of olive oil-rich diets. These diets enriched in oleic acid content are believed to possess chemopreventive effects against breast cancer.

However, several pathways are believed to explain the proliferative activity of oleic acid. In MCF-7 and MDA-MB-231 breast carcinoma lines, oleic acid enhanced metastasis and cellular proliferation through activation of free fatty acid receptor 1 (FFAR1) and FFAR4 receptors that are activated by medium-chain fatty acids like oleic acid.

This divergence — with some cell-line studies showing anti-tumor effects and others suggesting pro-proliferative activity — underscores the complexity and currently preliminary nature of the evidence. These effects have yet to be confirmed using randomized controlled trials to reveal solid conclusive evidence.

4.5 Neurological Health — Adrenoleukodystrophy (ALD) and Lorenzo's Oil

Two rare genetic disorders, ALD and adrenomyeloneuropathy (AMN), can cause a large build-up of certain chemicals called very long-chain fatty acids. The build-up of these fatty acids is thought to cause serious problems in the brain and body. Lorenzo's oil might help prevent some of this build-up.

A landmark two-year clinical trial at the NEJM level assessed this directly: the trial was conducted in 14 men with adrenomyeloneuropathy, 5 symptomatic heterozygous women, and 5 boys (mean age, 13 years) with preclinical adrenomyeloneuropathy, and patients ate a low-fat diet and received daily doses of glycerol trioleate oil (1.7 g per kilogram of body weight) and glycerol trierucate oil (0.3 g per kilogram). In this open trial, no evidence of a clinically relevant benefit from dietary treatment with oleic and erucic acids ("Lorenzo's Oil") was found in patients with adrenomyeloneuropathy.

While Lorenzo's oil lowered levels of C26:0 in plasma and adipose tissue, it failed to alter levels of C26:0 in the brain. The introduction of oleic acid (C18:1) followed by erucic acid (C22:1) in combination with a moderately low-fat diet resulted in a reduction of plasma very long-chain fatty acid (VLCFA) levels in 6–8 weeks in patients with ALD. Lorenzo's oil might help prevent nervous system problems in children who have ALD but haven't yet shown any symptoms.

4.6 Demyelinating Diseases and Nervonic Acid

Nervonic acid (C24:1ω-9) is a major constituent of the myelin membranes. Deposition of these fatty acids is rapid during brain growth in utero, the first months after birth, and during puberty.

Sphingolipids from post mortem multiple sclerosis (MS) brain have the same decreased 24:1(n-9) and increased 18:0 as seen in post mortem ALD brain. The 24:1(n-9) content of sphingomyelin is depressed in erythrocytes from multiple sclerosis patients.

Preclinical and clinical investigations have indicated that nervonic acid holds the potential to alleviate motor, cognitive, and neurological impairments. Preliminary evidence suggests that nervonic acid can also modulate cellular antioxidant defence systems and inflammation in neurodegenerative conditions, rendering it a promising therapeutic candidate for neurological diseases. The overall evidence base for nervonic acid supplementation in humans remains preliminary.

4.7 Liver Health

The Mediterranean diet, which is rich in olive oil and thus omega-9 fatty acids, has been shown to reduce liver fat and improve metabolic parameters in people with metabolic dysfunction-associated steatotic liver disease (MASLD). Omega-9 fatty acids help activate PPAR-α, a protein that enhances fat burning in the liver and reduces fat storage. Omega-9 stimulates the SIRT1 gene, which promotes cleaner burning of fats in the mitochondria. These fatty acids may reduce liver inflammation, which is critical in preventing progression from simple fatty liver to the more serious NASH.

While dietary omega-9 fatty acids (like those from olive oil) appear beneficial, excessive production of omega-9 fatty acids within the body has been associated with fatty liver in some studies. This highlights that the source and balance of these fats matter greatly. Most liver-related evidence is again derived from Mediterranean diet studies rather than omega-9 isolate trials, and human RCT evidence specific to isolated omega-9 supplementation for liver disease is limited.

5. Body Systems Associated with Omega-9 Fatty Acids

• Cardiovascular system: Modulation of LDL and HDL cholesterol levels, reduction of LDL oxidation susceptibility, improved endothelial function, anti-inflammatory activity in vascular walls.
• Metabolic/endocrine system: Improvement of insulin sensitivity, protection against saturated fat-induced insulin resistance, modulation of TNF-α's effect on pancreatic insulin secretion, potential reduction of type 2 diabetes risk.
• Nervous system: The omega-9 fatty acid 24:1ω9 is a major fatty acid in the membranes of nerves. Nervonic acid is essential for myelin synthesis and integrity; erucic acid serves as a precursor to nervonic acid and is used in ALD management.
• Immune system: Anti-inflammatory effects directed to attenuate inflammation in several physiological and pathological conditions, including wound healing and eye inflammation, by modulating neutrophil infiltration and altering inflammatory mediator production.
• Hepatic system: Activation of PPAR-α-mediated fat oxidation pathways, SIRT1 stimulation, and potential reduction of hepatic steatosis through dietary sources.
• Reproductive and mammary tissue: Associations studied in the context of breast cancer prevention, with complex and partially conflicting evidence regarding HER2 oncogene expression.
• Gastrointestinal system: Olive oil-based diets have been associated with gut microbiota modulation as part of the Mediterranean diet pattern, though this is not specifically attributable to oleic acid alone.

6. Dosage Forms and Reported Dosages

6.1 Dietary Intake Forms

Omega-9 fatty acids are most commonly consumed as a component of whole foods and culinary oils — primarily olive oil, high-oleic canola oil, high-oleic sunflower oil, avocado oil, and whole foods including avocados and tree nuts. No official recommended daily intake specifically for omega-9 fatty acids has been established by major health regulatory bodies. The lack of strict guidelines for omega-9 intake suggests that a balanced diet rich in a variety of healthy fat sources should provide sufficient omega-9 for most people.

6.2 Dosages Used in Clinical Studies

• PREDIMED trial (olive oil intervention): A Mediterranean diet reinforced with virgin olive oil at 50 mL/day was used in the PREDIMED Study.
• FDA qualified health claim (oleic acid): Consuming oils that provide about 20 grams (1.5 tablespoons) of oleic acid in place of dietary fats with higher amounts of saturated fat might reduce the risk of heart disease.
• Olive pomace oil trial: A randomized crossover intervention used 45 g daily of olive pomace oil or high-oleic acid sunflower oil as control, consumed for 4 weeks.
• Lorenzo's Oil (ALD treatment): In a clinical trial for adrenomyeloneuropathy, patients ate a low-fat diet and received daily doses of glycerol trioleate oil (1.7 g per kilogram of body weight) and glycerol trierucate oil (0.3 g per kilogram). Additionally, in another study, 300 mg/kg/day of erucic acid and 1.7 grams/kg/day of oleic acid (both contained in Lorenzo's oil) were used.
• Peanut oil (oleic acid, diabetes model): A dosage level of peanut oil for mice was chosen based upon studies using dietary oils in pigs supplemented to 40 g olive or sunflower oil per kg body weight; the exploratory mouse study employed 0.70 mL peanut oil, or approximately 18 g oil per kg body weight per day for three weeks.
• Animal model (OA for insulin sensitivity): Oleic acid and palmitoleic acid were each administered intragastrically at a dose of 100 mg/kg body weight in a prediabetes rat study.

6.3 Supplement Formulations

In combined omega fatty acid supplement preparations, dosages of omega-9 fatty acids in supplement formulations have been described in patent literature as ranging from about 50 mg/day to about 500 mg/day. These formulation ranges are not based on established recommended intakes but represent pharmaceutical formulation parameters.

7. Safety Considerations and Notable Interactions

7.1 General Safety of Oleic Acid

Oleic acid at dietary intakes derived from foods is widely considered safe. No toxicities have been reported or suspected with oleic acid at dietary concentrations. The U.S. FDA has granted a qualified health claim for high-oleic oils. There are no reports of toxicity from dietary consumption of erucic acid.

7.2 Erucic Acid: Historical Controversy and Resolution

The safety of erucic acid was largely debated, partly due to the Spanish Toxic Oil Syndrome (STOS), when severe cardiomyopathy was observed among consumers of rapeseed oils rich in erucic acid. It was proposed that erucic acid is highly toxic to cardiac mitochondria. However, several studies showed that STOS cases were only seen among consumers of rapeseed oils which were refined with carcinogenic aniline dyes; furthermore, opponents of the mitochondrial toxicity theory noted that critics had applied erucic acid at inapplicable doses.

Modern canola oil is bred to be low in erucic acid due to historical concerns about cardiac toxicity at very high doses. Initially, there were concerns surrounding the safety of Lorenzo's oil because erucic acid oils had been found to cause heart disease in rodents. Subsequent large-scale human studies at dietary exposure levels have not reproduced these findings. Regulatory agencies including EFSA and the FDA impose limits on erucic acid content in edible oils, and modern canola varieties are specifically cultivated to reduce erucic acid content to trace levels.

7.3 Lorenzo's Oil: Known Adverse Effects

Lorenzo's oil has been shown to cause a lowered platelet count, which can lead to thrombocytopenia and lymphopenia. Lorenzo's oil is taken orally and is generally well tolerated, although moderate platelet reduction and elevation of liver transaminases have been observed.

7.4 Elaidic Acid (Trans-Omega-9): A Critical Safety Distinction

It is essential to distinguish the naturally occurring cis form of omega-9 (e.g., oleic acid) from the trans isomer elaidic acid, which arises from industrial partial hydrogenation of vegetable oils. In general, administration of trans fatty acids (TFAs), including elaidic acid, represents health hazards in many studies. Higher circulating elaidic acid is connected with increased long-term morbidity and mortality in the general population. Elaidic acid should not be conflated with the cis omega-9 fatty acids found in natural food sources.

7.5 Circulating Oleic Acid and Cardiovascular Risk: A Complexity

A nuanced observational finding warrants mention. In the Multi-Ethnic Study of Atherosclerosis, higher levels of plasma oleic acid levels were associated with higher relative risks of prevalent carotid plaque, coronary artery calcification (CAC), and aortic valve calcification (AVC) in unadjusted and age-sex-race adjusted models; however, relations were rendered nonsignificant following full covariate adjustment. This suggests that circulating phospholipid oleic acid levels — which are influenced by endogenous synthesis as well as diet — may not directly parallel the effects of dietary oleic acid from food sources. Investigators interpret this distinction as reflecting that de novo lipogenesis (endogenous production of oleic acid) may behave differently from exogenously consumed oleic acid.

7.6 Caloric Density and Overall Fat Intake

The generally accepted recommendation is to not add more overall fats, but rather replace saturated and/or trans-fats with monounsaturated or polyunsaturated fats. Omega-9 rich oils are calorie-dense (approximately 120 calories per tablespoon), and excess intake of any fat — regardless of type — can contribute to caloric surplus. While dietary omega-9 fatty acids appear beneficial, excessive production of omega-9 fatty acids within the body has been associated with fatty liver in some studies.

7.7 Mead Acid Accumulation as an EFA Deficiency Marker

Essential fatty acid (EFA) deficiency induces skin rash, alopecia, growth disorders, and reproductive abnormalities, accompanied by the appearance of Mead acid in the blood. Mead acid accumulates in the body in response to a deficiency in the essential fatty acids, and there is some thought that Mead acid may compensate, with the decline in linoleic acid, in serving structural purposes in membranes. Elevated Mead acid is therefore a clinical marker for EFA deficiency rather than a supplement target, and conditions promoting its endogenous elevation signal nutritional insufficiency, not benefit.

7.8 Interactions with Drug Metabolism

No well-documented clinically significant pharmacokinetic drug interactions have been established specifically for oleic acid at normal dietary intake levels. In the context of Lorenzo's oil, the thrombocytopenic effects may interact with antiplatelet or anticoagulant therapies, but this applies only to the high therapeutic doses used in ALD treatment, not dietary consumption. The impact of olive oil on CYP enzyme expression or drug bioavailability has been studied primarily in the context of the polyphenol components of EVOO (notably oleuropein) rather than oleic acid per se.

References

• Omega-9 fatty acids: potential roles in inflammation and cancer management — PMC/PubMed Central
• The physiological and pathological properties of Mead acid, an endogenous multifunctional n-9 polyunsaturated fatty acid — PMC/PubMed Central
• High-oleic canola oil consumption enriches LDL particle cholesteryl oleate content and reduces LDL proteoglycan binding in humans — PMC/PubMed Central
• Olive pomace oil can improve blood lipid profile: a randomized, blind, crossover, controlled clinical trial — PMC/PubMed Central
• Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process — PMC/PubMed Central
• Oleic acid and peanut oil high in oleic acid reverse the inhibitory effect of insulin production of the inflammatory cytokine TNF-α — PMC/PubMed Central
• The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model — PMC/PubMed Central
• Omega-9 Oleic Acid, the Main Compound of Olive Oil, Mitigates Inflammation during Experimental Sepsis — PMC/PubMed Central
• Circulating oleic acid levels are related to greater risks of cardiovascular events and all cause mortality: the Multi-Ethnic Study of Atherosclerosis — PMC/PubMed Central
• The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription — PMC/PubMed Central
• The effects of extra virgin olive oil or butter on cardiovascular biomarkers in European and Chinese males in the UK: A pilot randomised crossover trial — PMC/PubMed Central
• Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells — PMC/PubMed Central
• The Effects of Omega-3 Polyunsaturated Fatty Acids on Breast Cancer as a Preventive Measure or as an Adjunct to Conventional Treatments — PMC/PubMed Central
• Nervonic acid in infant nutrition: a forward-looking approach to enhancing neurodevelopmental outcomes — PMC/PubMed Central
• Nervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts — British Journal of Pharmacology (2025)
• Nervonic Acid Attenuates Accumulation of Very Long-Chain Fatty Acids and is a Potential Therapy for Adrenoleukodystrophy — Neurotherapeutics
• Nervonic acid and demyelinating disease — ScienceDirect
• A Two-Year Trial of Oleic and Erucic Acids ("Lorenzo's Oil") as Treatment for Adrenomyeloneuropathy — New England Journal of Medicine
• Cognitive improvement effect of nervonic acid and essential fatty acids on rats ingesting Acer truncatum Bunge seed oil — Food & Function (RSC Publishing)
• Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases — Bentham Science/EurekaSelect
• Omega-9 Fatty Acid — ScienceDirect Topics Overview
• Individual omega-9 monounsaturated fatty acids and mortality — The Ludwigshafen Risk and Cardiovascular Health Study — ScienceDirect
• Oleic Acid: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews — WebMD/Natural Medicines
• Lorenzo's Oil — Wikipedia (citing published medical literature)
• What Are Omega-9 Fatty Acids? — OmegaQuant
• Erucic acid, a component of Lorenzo's oil used in treatment of adrenoleukodystrophy, acts antineoplastic in C6 glioma cell culture — PMC/PubMed Central
• HER2 (erbB-2)-targeted effects of oleic acid in breast cancer cells — PubMed
• Phosphorylation of Elovl5 changes its substrate preference to synthesize Mead acid in response to essential fatty acid deficiency — bioRxiv